The View from Here
Investing in the Future of Health On Oct. 17, 2006, the U.S. population went past the 300 million mark. Since the median age of the population is currently 36.2 years, half of our population was not even born in November 1967 when we passed the 200 million milestone. The next 100 million will be here before some of us have gone; if present trends continue, the United States will have 400 million people sometime in the early 2040s. This ought to cause some real soul searching about the health investments we are making.
Over the past 30 years, the United States has become complacent about continued public investments in public health. We have spent public funds on research that has provided visible strides in treatments for cancer and cardiac diseases, and tantalizing promises of curative therapies for neurological diseases. Our increased spending on health care per person reflects private sector investments that have produced marvelous new diagnostic imaging and noninvasive surgical techniques, powerful drugs that can fight cancers and enable organ transplants, mechanical engineering advances in joint replacements, and a variety of expensive, as well as cheap, drugs for conditions ranging from hypertension to Parkinson's. Because these benefits are financed for most Americans by health insurance, more people are being diagnosed appropriately and treated for these conditions. But this third-party payment system that includes private insurance, Medicare, and Medicaid is not set up to focus on community health issues or on the larger picture of preparedness for public health threats.
Community Health Issues
Many illnesses and medical conditions that cause the greatest medical expenditures are linked to issues that go beyond the individual's control. Obesity and asthma are two good examples; they also are significant comorbidities for conditions that account for the biggest shares of the country's total health spending.
In 1997, among the 15 conditions with the highest total spending, cerebrovascular disease, diabetes, heart disease, and kidney disease had the highest median spending per person for individuals with any medical expenses (Cohen and Krauss 2003) . Except for heart disease, the growth in spending for these conditions between 1987 and 2000 was due to the increased prevalence of treatment for people with these diseases (Thorpe, Florence, and Joski 2004) . The rise in the number of people considered to be obese was a significant factor in the increase in treatment of diabetes and heart disease (Thorpe et al. 2005) . Being obese or overweight increases the risks of these diseases as it does for osteoarthritis. Since heart disease, diabetes, and osteoarthritis together accounted for almost 10% of our annual health spending in 1997 (Cohen and Krauss 2003) , the relatively sudden jump over the last 20 years in the percentage of people who are overweight has troubling implications for future health care spending. 1 The increase in the number of overweight or obese people is a community problem, and we should not expect employers or insurers to deal with it on their own. Communities are largely responsible for creating opportunities for children and adults to get exercise, and setting standards for foods served in school cafeterias and offered in vending machines. At the national level, we are all one big community when it comes to policies and regulations related to the foods we eat. A concerted effort by nutrition experts finally has led to more explicit labeling of food contents and the elimination of trans fats from many storebought foods. New York City's Mayor Michael Bloomberg recently proposed banning trans fats in restaurant foods, as has been done in Denmark.
But what do we know about the effects of high-fructose corn syrup, which is ubiquitous in soft drinks, fruit drinks, and mass-produced bakery products because it is so cheap? High-fructose corn syrup mixes well with other ingredients in foods (including ''healthy'' foods like yogurt) and helps extend their shelf life. It began to be used widely by large food producers about 25 years ago -which is when the prevalence of being overweight and obese began to rise. Is there something about the slightly higher amount of fructose in this sweetener, compared to sucrose, that affects our metabolism so that we gain weight? Finding the answers to this requires a determined public health effort. Until we establish the effects of high-fructose corn syrup, we cannot expect individuals to have the knowledge with which to make food choices.
Asthma -especially the rising incidence of childhood asthma -is a second condition with implications for our future health spending. As with obesity, it, too, is a community issue. Are schools too often located near busy roads where car and truck exhaust remains in the air? By January 2007, new trucks with diesel engines must have scrubbers to remove fine particulates that these engines emit; by 2008, new diesel engine cars also will be required to have such scrubbers. But older vehicles are grandfathered and still will release emissions. Are we allowing a whole generation of children to be exposed to such particulates? Other factors also may affect the probability of a child being asthmatic. In efforts to reduce heating and air conditioning expenses, are school buildings not exchanging classroom air often enough? Are building materials in new homes and older apartment buildings contaminated by harmful substances or somehow more hospitable to organisms such as dust mites?
Preserving clean air and water is not a new community health issue. Modern public health efforts started more than 100 years ago with studies and then efforts to kill cholera and other bacteria in drinking water supplies. But in an era of rising demand for energy resources, mining for coal and extracting oil from oil sands has a byproduct of heavy metals (e.g., mercury, arsenic, beryllium) that are flowing into ground water supplies. Such metals are known to cause neurological damage to animals and humans. The push for carbon fuel extraction has to be balanced by the need to prevent such calamities and preserve clean water for future generations.
National Public Health Issues
Full-scale national efforts are the only way to address some public health issues. To name just two, we are not prepared for a flu epidemic or epidemic caused by new pathogens or drug resistant strains of known pathogens such as tuberculosis (TB) and malaria. It is urgent that we increase funding for research to learn more about how influenza, TB, and malaria work, and then to create vaccines for them. Such research also ought to enable us to develop medicines and vaccines for other new viruses.
The slow response to Hurricane Katrina's devastation last year is a good indicator of the type of action we might see were an epidemic to break out tomorrow. States have been working to create plans for how public health authorities and medical personnel would respond to an epidemic or bioterrorist attack. Although the probability of such events is small, improving our preparedness needs to have a higher priority than it does now. Writer John Barry describes the planning for the 1918 flu epidemic, which was inadequate despite having the best of the country's civilian and Army medical personnel in charge (Barry 2004) . Even though this group suspected an epidemic was imminent six months before it occurred, it was unable to get the country to take the necessary preventive steps when the flu first broke out. We do not want to be in the same position a century later.
Beyond being positioned to respond to epidemics, the growing incidence of Alzheimer's and Parkinson's diseases, as well as other neurological degenerative conditions, raises questions about how exposure to influenza and other viruses in childhood may have secondary effects many years later. Streptococcus-related infections, such as scarlet fever, are rare today, but are known risk factors in heart disease. Given the health care spending attributed to neurological conditions, we should increase efforts to understand how infections in one stage of life increase the risk of developing a condition or disease decades later -and then figure out how to reduce that risk.
Reassert Public Responsibility
Over the last 25 years, we have shifted toward a world of increased personal responsibility for our health and of greater reliance on the private sector rather than government research facilities. But the health-related issues described here are beyond the ability of any one person to control. Nor are they the responsibility of individual health insurers, health plans, or employers, all of whom have little ability to directly affect them. Similarly, pharmaceutical firms should not be responsible for the basic research necessary for understanding how pathogens attack the human body or how exposure to a virus years ago could lead to degenerative conditions decades later. Such knowledge is a public good and should be financed as such.
Unless communities and the nation as a whole act to change these alarming health trends, these issues surely will raise health care spending within the next 20 years. This will have grave consequences for the well-being of people living today and people who will join the 400 million in the next 37 years. For their sake, we need to sharply increase our investments in public health issues.
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